JPRN-UMIN000019660已完成未知
Study to evaluate release of glucose toxicity associated with SGLT2 inhibitors administered in patients with metabolic syndrome in type 2 diabetes - Study to evaluate release of glucose toxicity associated with SGLT2 inhibitors administered in patients with metabolic syndrome in type 2 diabetes
Medical Corporation KYOSOKAI AMC Nishi Umeda Clinic0 个研究点目标入组 30 人开始时间: 2015年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with type 1 diabetes (2)Patients with a history of severe ketosis, diabetic coma, or diabetic pre-coma within 6 months prior to the start of study (3)Patients with severe infection or serious trauma, or in a pre- or post-operative phase (4)Patients with a history of hypersensitivity to the components of the study drug (5)Patients with severe renal dysfunction (eGFR <30 mL/min/1.73 m2) or end-stage renal failure undergoing dialysis (6)Patients with serious hepatic dysfunction (7)Pregnant or lactating women, or those expecting to become pregnant during the study period (8)Patients judged inadequate to enroll in the study at the discretion of principal investigator or subinvestigator
研究者
相似试验
招募中
4 期
A trial investigating the effect on blood glucose after the injection of fast-acting insulin aspart (Fiasp®) in comparison to insulin aspart (NovoRapid®) around exercise in participants with type 1 diabetesE10Type 1 diabetes mellitusDRKS00015855Forschungseinheit für interdisziplinäre metabolische Medizin, Medizinische Universität Graz44
进行中(未招募)
1 期
A study that investigates the effects of fast-acting insulin (FIASP®) on blood sugars in comparison to a different fast-acting insulin (NovoRapid®) around exercise in participants with type 1 diabetesMedDRA version: 20.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus System Organ Class: 100000004861Type 1 DiabetesEUCTR2019-001281-14-ATMedical University of Graz44
已完成
不适用
Pilot study to investigate glucose concentrations in people without diabetes mellitus during oral glucose tolerance test (oGTT)E14Unspecified diabetes mellitusDRKS00026765Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm (IfDT)42
已完成
不适用
Study to evaluate intestinal glucose excretion using 18F-FDG-PET/MR enterography in patients not taking metformitype 2 diabetes mellitusJPRN-UMIN000045137Kobe university5
尚未招募
不适用
Study to evaluate intestinal glucose excretion using 18F-FDG-PET/MR enterography in patients taking imeglimitype 2 diabetes mellitusJPRN-UMIN000045345Kobe university5
